Mabtech, a biotech company specializing in immunoassays for research and clinical diagnostics, sought to enhance the efficiency, user-friendliness, and accuracy of their key products like the FluoroSpot, ELISpot, and FociSpot readers. These improvements were crucial to strengthen their tools used in vaccine development and disease characterization amidst the global fight against diseases caused by viruses, bacteria, and parasites.
